Drospirenone

This classification denotes a therapeutic progestin with the molecular formula C24H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N295J34A25, chemically known as 1,2-dihydrospirorenone but generally known as drospirenone, which bears US NIH Compound Identifier 68873. European Medicines Agency schedules Drospirenone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06413MIG. The term DROSPIRENONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). DROSPIRENONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule drospirenone under HS 29372900 and SITC 54153. As of Q4 2014, DROSPIRENONE remains the US FDA Preferred Term for this commodity. Drospirenone bears US NLM identifiers UMLS ID C0043822 and NCI Concept Code C47502. SMILES: O1C2(C3C(C4C2(CCC2C4C4C(C4)C4=CC(=O)CCC24C)C)C3)CCC1=O.